Objective-The transcription factor early growth response (EGR)-1 has been implicated as a key vascular phenotypic switch through its control of inducible transcription. EGR-1 autoregulation, and histone modification in the EGR-1 promoter, represent key mechanisms in EGR-1 control, but have not been explored. Methods and Results-We demonstrate that EGR-1 regulates its own transcription and that this involves histone H3 phosphorylation and acetylation. EGR-1 transactivates its promoter in smooth muscle cells exposed to interleukin (IL) 1␤ through a novel cis-acting element (Ϫ211/Ϫ203). PD98059, which inhibits mitogen-activated protein kinase kinase/extracellular regulated kinase (MEK/ERK) attenuates IL-1␤-inducible phosphorylation of extracellular signalregulated kinase 1/2 and mitogen and stress-activated protein kinases 1/2; and reduces levels of phosphorylated and acetylated histone H3. Histone deacetylase inhibition enhances EGR-1 transcription in response to cytokine. Conversely, suppression of histone modification with mitogen and stress-activated protein kinase 1/2 short interfering RNA, or the histone H3 acetyltransferase inhibitor Garcinol, inhibits IL-1␤-inducible EGR-1 transcription. EGR-1 interacts with the acetyltransferase p300. Acetylated H3 and phosphorylated H3 are enriched at the promoter of EGR-1; and EGR-1 is enriched at the promoters of tissue factor and plasminogen activator inhibitor 1 in response to IL-1␤, and attenuated by PD98059, Garcinol, and mitogen and stress-activated protein kinase 1/2 short interfering RNA. Conclusion-IL-1␤ induction of EGR-1 transcription involves histone H3 phosphorylation, acetylation, and autoregulation by EGR-1. (Arterioscler Thromb Vasc Biol. 2010;30:536-545.)
also known as NGFI-A, Zif268, Krox24, and Tis8) is an inducible zinc finger transcription factor that plays a critical role in controlling cell growth, proliferation, differentiation, and apoptosis. [1] [2] [3] [4] [5] EGR-1 belongs to a family of zinc finger transcription factors that also includes EGR-2, EGR-3, EGR-4, EGR-␣, and the Wilm tumor gene product. 6 EGR-1 contains a highly conserved DNA-binding domain (three zinc finger domains of the C2H2 subtype), an activation domain, a repression domain, and a nuclear localization signal. 7, 8 Carman and Monroe 9 identified an activation domain between amino acids 174 and 270, a serine/threonine/prolinerich region that is critical for its activity. Mutants lacking this domain perturb wild-type EGR-1 function. 9 EGR-1 regulates the transcription of target genes by binding to GC-rich consensus DNA elements present in the regulatory regions in vascular pathophysiologically relevant genes, such as insu-linlike growth factor II, platelet-derived growth factor A and B chains, tissue factor, fibroblast growth factor 2, transforming growth factor ␤1, urokinase plasminogen activator, and plasminogen activator inhibitor (PAI) 1. 5,7,10 -13 EGR-1 also regulates the expression of its corepressor nerve growth factor I-A binding protein-2. 11 Functional cis-acting elements within the human EGR-1 promoter have been identified in different cell types and include serum-response elements (SREs) and sites for Elk1, Ets, AP-1, and nuclear factor (NF)-B binding sites. 14, 15 EGR-1 is induced by a wide range of stimuli, including growth factors, cytokines, ionizing radiation, UV light, and mechanical injury. 16 -19 Increasing evidence indicates that EGR-1 activation may function as a key switch in many pathological processes, including cancers and cardiovascular diseases. EGR-1 has been indicated in atherosclerosis, intimal thickening after acute vascular injury, ischemia, angiogene- Figure 1 . Early growth response (EGR) 1 transactivates its own transcription via a novel functional EGR-1 element within its promoter. A, The EGR-1 promoter sequence was retrieved from the University of Calif., Santa Cruz genome browser. Consensus elements are as follows: nuclear factor-B, GGGRNNYYY; Elk1, MMGGAW; serum-response element, CCWWWWWWGG; EGR-1, WTGCGTGGGCGK. B, Human aortic smooth muscle cells (HASMCs) grown to 70% to 80% confluence were transfected with EGR-1 expression vector (pCB6-EGR-1) or empty vector (pCB6), and EGR-1 promoter-reporter construct containing wild type or mutant putative EGR-1 binding site. The cells were incubated for a further 24 hours in serum-free medium before determination of relative luciferase activity, as described in the "Methods" section. Western blotting 24 hours after transfection confirmed that pCB6 -EGR-1, but not the empty vector (pCB6 ϩ ), increased EGR-1 levels in the HASMCs. Increased EGR-1 immunoreactivity represents total EGR-1, which includes both endogenous and exogenous proteins. C, Rat aortic smooth muscle cells (RASMCs) were transfected with empty plasmid or wild-type EGR-1 sis, allograft rejection, and cardiac hypertrophy. 17 EGR-1 is overexpressed in esophageal cancer and plays a key role in mediating and maintaining growth-related oncogene/CXC chemokine receptor 2 proliferative signaling. 20 Primary human prostate carcinomas express high levels of EGR-1, [21] [22] [23] and several EGR-1 target genes (eg, insulinlike growth factor II, transforming growth factor ␤1, and platelet-derived growth factor A-chain) have been implicated in prostate tumorigenesis. 22 EGR-1 knockdown inhibits prostate cancer cell proliferation and tumor development in transgenic adenocarcinoma mouse prostate mice. 24 Furthermore, an indispensable role for EGR-1 has been demonstrated in breast cancer cell proliferation, migration, and invasion in nude mice using DNAzymes. [25] [26] [27] [28] This is due, in part, to EGR-1 regulation of angiogenesis. 26 Although EGR-1 plays a key role in many pathological processes, it is unknown whether EGR-1 regulates its own transcription. Moreover, information on the role of chromatin remodeling and histone modification in the control of EGR-1 transcription is lacking. Herein, we provide novel insights on the role of EGR-1 and histone H3 modifications in the transcriptional regulation of the human EGR-1 gene.
Methods
Primary human aortic smooth muscle cells (HASMCs) and rat aortic smooth muscle cells were purchased from the American Type Culture Collection and cultured at 37°C in a humidified atmosphere of 5% carbon oxide and 95% air in Waymouth medium containing 10% fetal bovine serum. SMCs grown to 90% confluence were starved of serum for 24 hours and then treated with 10 ng/mL of interleukin (IL) 1␤ for various time intervals; where indicated, they were treated, after 1 hour of incubation, with inhibitors such as PD98059, SB202190, BAY 11 to BAY 7085, or Oridonin. Cells were used between passages 5 and 8.
Details on the generation of promoter reporter constructs, sitedirected mutagenesis, transient transfection, luciferase assays, realtime quantitative reverse transcription-polymerase chain reaction (RT-PCR), immunocytofluorescence, Western blot analysis, phosphorylation and acetylation of histone H3, electrophoretic mobilityshift assay, immunoprecipitation experiments, chromatin immunopre-cipitation (ChIP), and statistical analysis are found in the Supplemental Materials section, available online at http://atvb.ahajournals.org.
Results

EGR-1 Regulates Transcription of Its Own Gene
EGR-1 is implicated as a key regulatory switch in a wide variety of vascular disorders through its control of inducible transcription. 5, 17 Although the EGR-1 promoter has previously been studied, 11, 15 it is unknown whether EGR-1 can control its own transcription. Moreover, the critical role of histone modification in EGR-1 transcription is completely unknown. Bioinformatic analysis of the proximal region of the EGR-1 promoter shows the existence of numerous conserved putative cis-acting elements, including SREs, and motifs for Ets, Elk1, and NF-B. Interestingly, the EGR-1 promoter contains a putative atypical binding motif (5Ј-GCGCGGGCG-3Ј) for EGR-1 located at Ϫ211/Ϫ203 (Figure 1A) . We used the proinflammatory cytokine IL-1␤ as a model agonist of EGR-1 to gain valuable insights into the EGR-1 transcription in HASMCs. Quantitative real-time RT-PCR showed both a time-and dose-dependent induction in EGR-1 messenger RNA (mRNA) expression in HASMCs exposed to the IL-1␤ (Supplemental Figure IA and B ). EGR-1 was induced by as little as 2.5 ng/mL of IL-I␤ (Supplemental Figure IA) and peaked at 30 minutes in cells exposed to 10 ng/mL of IL-1␤ (Supplemental Figure IB) . Immunofluorescence staining revealed that IL-1␤ triggered the rapid accumulation of EGR-1 in HASMC nuclei within 0.5 to 1.0 hours (Supplemental Figure IC ), which correlates with the time course of IL-1␤-inducible EGR-1 expression (Supplemental Figure IB) .
Overexpression of EGR-1 in HASMCs transfected with a luciferase reporter construct driven by 450 base pairs of the human EGR-1 promoter spanning the putative EGR-1 binding motif significantly increased luciferase activity ( Figure  1B, upper) . When the -208 CGG -206 motif in the promoter was mutated to -208 AAA -206 , induction by EGR-1 of the EGR-1 promoter was abolished ( Figure 1B , lower). Western blotting . reporter or a series of mutant EGR-1 promoter-reporter plasmids for 24 hours. The cells were serum starved for another 24 hours and stimulated with 10 ng/mL of interleukin (IL) 1␤ for 30 minutes before the assessment of relative luciferase activity. D, An electrophoretic mobility-shift assay (EMSA) was performed with 32 phosphorylated oligo EGR-1 -225/-187 or messenger EGR-1 -225/-187 units, and increasing amounts of EGR-1-glutathione S-transferase protein, 4 and 8 g. The antibody used (sc-110; Santa Cruz Biotechnology) targets native EGR-1. E, Twenty-four hours after starvation, HASMCs were exposed to 10 ng/mL of IL-1␤ for 30 minutes. Conventional chromatin immunoprecipitation (ChIP) (right) and real-time ChIP (lower) were performed with EGR-1 antibodies or IgG, as described in the "Methods" section. Quantitation of EGR-1 enriched at its promoter incorporates an IgG control, which was subtracted from the EGR-1 value before quantitative comparison. The asterisk indicates PϽ0.05.
confirmed that pCB6-EGR-1, but not the empty vector (pCB6 ϩ ), increased EGR-1 levels in the HASMCs ( Figure  1B , lower, inset). Luciferase activity was induced by IL-1␤ in SMCs transfected with wild-type pGL3-450EGR-1-luc ( Figure 1C ). IL-1␤ responsiveness of the EGR-1 promoter was attenuated in cells transfected with the EGR-1 mutant promoter-reporter construct ( Figure 1C ). Mutation of SREs in the promoter also abolished IL-1␤ inducibility ( Figure 1C ). In contrast, mutation of the NF-B element had no effect on both basal expression and inducibility of EGR-1. Electrophoretic mobility shift analysis using a double-stranded oligonucleotide spanning the putative EGR-1 binding site (Oligo EGR-1 -225/-187 ) and recombinant EGR-1 protein revealed the formation of an EGR-1/DNA complex, which was supershifted by EGR-1 antibodies ( Figure 1D ). In contrast, the -208 CGG -206 to -208 AAA -206 mutation in Oligo EGR-1 -225/-187 failed to support the complex formation with recombinant EGR-1 protein ( Figure 1D ). ChIP analysis, using conventional PCR, confirmed that IL-1␤ induced the interaction of EGR-1 with its own promoter ( Figure 1E , top right). Moreover, real-time ChIP revealed the enrichment of EGR-1 protein at the EGR-1 promoter in HASMCs exposed to IL-1␤ ( Figure 1E , lower). Therefore, by using a variety of approaches, these results demonstrate that IL-1␤-inducible EGR-1 binds to, and transactivates, its own promoter.
IL-1␤ Stimulates EGR-1 Expression in HASMCs via the MEK-ERK1/2 Pathway
To identify the signaling pathway(s) mediating IL-1␤ induction of EGR-1, we first evaluated the influence of IL-1␤ on levels of phosphorylated extracellular signal-regulated kinase (ERK) 1/2, phosphorylated p38, and phosphorylated c-Jun NH 2 -terminal kinases 1/2 (JNK1/2) in this cell type. IL-1␤ activated ERK1/2 within 15 minutes (Supplemental Figure  IIA and B) . The cytokine increased levels of phosphorylated p38, albeit less impressively (Supplemental Figure IIA) , and had no effect on levels of phosphorylated JNK1/2 or phosphorylated c-Jun (Supplemental Figure IIA) . Levels of phosphorylated c-Jun were also unaffected (Supplemental Figure  IIA) . Because Elk1 is immediately downstream of ERK1/2, we assessed the effect of IL-1␤ on Elk1 phosphorylation in the HASMCs. Levels of phosphorylated Elk1 in nuclear extracts increased within 15 minutes (Supplemental Figure  IIC) . As expected, IL-1␤ also increased p65 levels in the nucleus (Supplemental Figure IIC) . These results indicate that ERK1/2-Elk1, p38, and NF-B pathways are activated in HASMCs in response to IL-1␤.
Next, HASMCs were treated with 10 ng/mL of IL-1␤ in the absence or presence of various concentrations of PD98059 (MEK-ERK1/2 inhibitor), BAY 11 to 7085, and Oridonin (2 NF-B inhibitors) or SB202190 (a p38 inhibitor); then, the EGR-1 mRNA levels were examined. Quantitative real-time RT-PCR analysis revealed that PD98059, 5 to . Pathways mediating interleukin (IL) 1␤-dependent early growth response (EGR) 1 expression in human aortic smooth muscle cells (HASMCs). A, HASMCs were starved for 24 hours and stimulated with 10 ng/mL of IL-1␤ for 30 minutes or treated with different concentrations of PD98059, SB202190, BAY 11 to 7085, or Oridonin for 1 hour before IL-1␤ treatment. Total RNA was isolated and subjected to real-time reverse transcription-polymerase chain reaction using EGR-1 primers, as described in the "Methods" section. B, Western blot analysis was performed using antibodies to phosphorylated extracellular signalregulated kinase (ERK) 1/2 or ERK1/2, phosphorylated p38 or p38, and EGR-1 or ␤-actin. The asterisk indicates PϽ0.05.
10 mol/L, inhibits IL-1␤-inducible EGR-1 mRNA expression in a dose-dependent manner (Figure 2A , column 2 versus column 3; and Figure 4 ), whereas SB202190, 5 to 10 mol/L, stimulates EGR-1 mRNA expression (Figure 2A , column 2 versus columns 9 and 10). In contrast, BAY 11 to 7085 and Oridonin had no effect on IL-1␤-inducible EGR-1 expression (Figure 2A , column 2 versus columns 5 and 6 or 7 and 8). PD98059 completely inhibits IL-1␤-inducible EGR-1 protein expression ( Figure 2B, left) , whereas SB202190 stimulates EGR-1 protein expression ( Figure 2B, right) . This demonstrates the negative regulatory role of p38 and the positive regulatory role of ERK1/2 in IL-1␤-inducible EGR-1 expression. These results indicate that, in HASMCs, IL-1␤ activates EGR-1 via the MEK-ERK1/2-Elk1 pathway.
Influence of IL-1␤-Inducible Histone H3 Modifications on EGR-1 Transcription
Although chromatin remodeling is a key process in transcriptional regulation, 29 surprisingly there is nothing known about the role of histone modifications in the control of EGR-1 transcription. Mitogen and stress-activated protein kinases (MSK1/2) mediate the phosphorylation of histone H3. 30, 31 Having demonstrated that PD98059 inhibits IL-1␤-inducible ERK1/2 activation (Figure 2B , left) and EGR-1 expression in HASMCs (Figure 2A and B) , we next investigated the effect of MEK-ERK1/2 inhibition on levels of phosphorylated MSK1 and MSK2 in HASMCs treated with IL-1␤. MSK1 and MSK2 were phosphorylated within 30 minutes of exposure to IL-1␤ ( Figure 3A ). PD98059 suppressed MSK1 and MSK2 phosphorylation in a dose-dependent manner ( Figure  3A) . H3 phosphorylation and acetylation also increased in response to IL-1␤, as did ribosomal S6 kinase phosphorylation 32 ; each was reduced by MEK-ERK1/2 inhibition ( Figure  3A) , demonstrating the importance of ERK1/2-MSK1/2 signaling in IL-1␤-mediated histone H3 phosphorylation and acetylation. To establish a causal relationship between histone H3 modification and EGR-1 transcription, we then determined the levels of phosphorylated, acetylated, and methylated H3 in HASMCs treated with IL-1␤ over time. Western blot analysis indicated a rapid and transient induction in both phosphorylated and acetylated H3 (Supplemental Figure 3A and B) but not methylated H3 (Supplemental Figure IIIA) . We further explored the role of H3 acetylation in IL-1␤-mediated EGR-1 transcription in HASMCs using Figure 3 . Histone H3 modification is associated with inducible early growth response (EGR) 1 transcription. A, Human aortic smooth muscle cells (HASMCs) were starved for 24 hours and treated with 10 ng/mL of interleukin (IL) 1␤ for 30 minutes or treated with 5 and 10 mol/L of PD98059 1 hour before IL-1␤ treatment. Whole cell lysates were prepared in RIPA buffer and separated on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Western blot analysis was performed using antibodies specific to phosphorylated mitogen and stress-activated protein kinase (MSK) 1/2, phosphorylated H3, acetyl-H3, total H3, phosphorylated ribosomal S6 kinase (RSK), or ␤-actin, as described in the "Methods" section. B, HASMCs were starved for 24 hours and treated with 2.5 mol/L of suberoylanilide hydroxamic acid (SAHA) for 4 hours before 30-minute incubation with IL-1␤, 10 ng/mL. Whole cell lysates were prepared in RIPA buffer and separated on 10% SDS-PAGE. Western blot analysis was performed as described in the "Methods" section. Total RNA was isolated and subjected to real-time reverse transcription-polymerase chain reaction (RT-PCR) with EGR-1 primers, as described in the "Methods" section. The asterisk indicates PϽ0.05.
the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA). 33 SAHA caused a dramatic increase in the levels of acetylated H3 ( Figure 3B ). Interestingly, it also increased the levels of phosphorylated H3 ( Figure 3B ). Real-time RT-PCR revealed that EGR-1 expression induced by IL-1␤ was further increased by SAHA ( Figure  3B ). This indicates the permissive role of H3 acetylation in IL-1␤-inducible EGR-1 expression.
To further explore the role of histone acetylation and phosphorylation in IL-1␤-inducible EGR-1 transcription, we treated HASMCs with Garcinol, an inhibitor of H3 acetyltransferases, 34 or transfected the cells with short interfering RNA (siRNA) targeting MSK1 and MSK2. H3 phosphorylation and acetylation induced by IL-1␤ were reduced by MSK1 and MSK2 siRNA ( Figure 4A ). H3 acetylation was inhibited by Garcinol, with less effect on H3 phosphorylation ( Figure 4A ). Real-time RT-PCR revealed that IL-1␤-inducible EGR-1 expression is indeed reliant on H3 acetylation and phosphorylation ( Figure 4B ). Co-IP analysis revealed the formation of an IL-1␤-inducible complex between EGR-1 and the histone acetyltransferase p300 in HASMC extracts ( Figure 4C, upper) . EGR-1 and p300 also interact as recombinant proteins (Figure 4C, lower) . Real-time ChIP showed the enrichment of p300 at the EGR-1 promoter in response to IL-1␤ ( Figure 4D) , whereas transient transfection analysis demonstrated that p300 stimulates EGR-1 promoter activity through the EGR-1 binding site ( Figure 4E ). Moreover, both phosphorylated and acetylated H3 are enriched, together with EGR-1 itself, at the EGR-1 promoter in response to IL-1␤ stimulation ( Figure 4F) . Figure 3A . Inhibition of histone H3 modification by either short interfering RNA (siRNA) or inhibitor attenuates interleukin (IL) 1␤-induced early growth response (EGR) 1 transcription. Human aortic smooth muscle cells (HASMCs) were transfected with 0.05 mol/L of mitogen and stress-activated protein kinase (MSK) 1 siRNA, MSK2 siRNA, or control siRNA for 24 hours. Alternatively, 18 hours after starvation, the cells were treated with Garcinol for 6 hours. The cells were then incubated with IL-1␤, 10 ng/mL, for 30 minutes. A, Western blot analysis of whole-cell lysates for phosphorylated H3, acetyl H3, total H3, or ␤-actin (left). The effect of MSK1 and MSK2 siRNA on levels of MSK1 and MSK2 is shown (right). B, Real-time reverse transcription-polymerase chain reaction (RT-PCR) with total RNA and EGR-1 primers. C, EGR-1 and p300 interact in cells exposed to IL-1␤. Extracts from untreated or IL-1␤-treated HASMCs were incubated with EGR-1 antibodies, pulled down with protein A/G beads, and immunoblotted for p300 or EGR-1. An immunoblot for p300 is also shown; this serves as a loading control for immunoprecipitated p300 (upper). Alternatively, recombinant p300, 0.6 g, was incubated with glutathione S-transferase-EGR-1, 1 or 2 g, pulled down with glutathione-agarose beads, then blotted with p300 antibodies (middle), or pulled down with p300 antibodies and protein A/G, and blotted with glutathione S-transferase antibodies (lower). D, Real-time chromatin immunoprecipitation (ChIP) with p300 antibodies and amplification of the EGR-1 promoter. E, Transient transfection analysis in rat aortic smooth muscle cells (RASMCs) transfected with pCB6 -EGR-1 or pCMV␤-p300. Luciferase assays were performed as described in the "Methods" section. F, Enrichment of phosphorylated and acetylated H3 at the EGR-1 promoter in response to IL-1␤. Chromatin from HASMCs stimulated with 10 ng/mL of IL-1␤ was sonicated and immunoprecipitated using ChIP-grade antibodies to acetyl-H3, phosphorylated H3, total H3, and EGR-1, and DNA was amplified by real-time ChIP. Enrichment was normalized to that obtained with control rabbit antibody and expressed as fold increase over that measured at a control region in the LMO2 proximal promoter. The asterisk indicates PϽ0.05.
there is no change in total H3 levels in cells exposed to the cytokine. We used an antibody against total H3 (nonacetylated and nonphosphorylated forms) as a control in the ChIP assay to show that H3 acetylation and phosphorylation are increased at the EGR-1 promoter in response to IL-1␤. Figure  4F demonstrates that total H3 occupancy of the EGR-1 promoter does not differ between untreated and IL-1␤treated samples. Taken together, these data indicate that H3 Figure 5 . Early growth response (EGR) 1 is enriched at the promoters of EGR-1-dependent genes in a mitogen and stress-activated protein kinase (MSK)-and histone H3 acetyltransferase-dependent manner. Twenty-four hours after starvation, human aortic smooth muscle cells (HASMCs) were exposed to 10 ng/mL of interleukin (IL) 1␤ for 30 minutes. Chromatin immunoprecipitation (ChIP) and realtime ChIP were performed with EGR-1 antibodies or control IgG, amplifying the plasminogen activator inhibitor (PAI) 1 promoter (A) or the TF promoter (B), as described in the "Methods". C, Twenty-four hours after starvation, HASMCs were exposed to 10 mol/L of PD98059 for 1 hour and 20 mol/L of Garcinol for 4 hours, before treatment with 10 ng/mL of IL-1␤ for 30 minutes. Real-time ChIP was performed with EGR-1 antibodies or IgG, as described in the "Methods" section. D, EGR-1 short interfering RNA (siRNA) inhibits IL-1␤induced EGR-1, PAI-1, and tissue factor expression. Serum-arrested HASMCs were transfected with 0.1 mol/L of siRNA using FuGENE6 and harvested 30 minutes or 2 hours after the addition of 10 ng/mL of IL-1␤; Western blotting was then performed. The asterisk indicates PϽ0.05. acetylation and phosphorylation, and EGR-1, are increased at the EGR-1 promoter in response to IL-1␤.
EGR-1 Is Enriched at the Promoters of EGR-1-Dependent Genes in an MSK-and Histone H3 Acetyltransferase-Dependent Manner
To determine whether IL-1␤-inducible EGR-1 functionally regulates transcription of inflammatory mediators, we treated HASMCs with a course of IL-1␤, and the mRNA levels of tissue factor and PAI-1 were examined. Quantitative realtime RT-PCR showed a time-dependent induction in both TF and PAI-1 in HASMCs exposed to IL-1␤ (Supplemental Figure IV) , consistent with the time-course induction of EGR-1 expression (Supplemental Figure IA) . Both conventional and real-time ChIP revealed the enrichment of EGR-1 at the promoter region of TF and PAI-1 in response to IL-1␤ ( Figure  5A and B) , which is suppressed by PD98059, Garcinol, and MSK1/2 siRNA ( Figure 5C ). EGR-1 siRNA blocked IL-1␤inducible EGR-1, PAI-1, and tissue factor expression ( Figure  5D ). Thus, EGR-1 induced by IL-1␤ binds to and induces TF and PAI-1 expression, in an MEK/ERK, MSK, and H3 acetyltransferase-dependent manner (Figure 6 ).
Discussion
The proinflammatory cytokine IL-1␤ has long been implicated in the pathogenesis of cardiovascular disease. IL-1␤ and its receptor are expressed in atheromatous tissue; IL-1␤ activates macrophages, stimulates SMC proliferation, and upregulates endothelial adhesion molecule expression. 35 The zinc finger transcription factor EGR-1 is a "master regulator" in that it controls the expression of many pathophysiologically relevant genes. 5,17 EGR-1-dependent genes have been strongly implicated in the initiation and progression of atherosclerosis and postangioplasty restenosis. 36 -38 Understanding the mechanisms regulating the inducible expression of EGR-1 in vascular cells by IL-1␤ would provide an important backdrop for future interventional approaches targeting this transcription factor.
To our knowledge, this study has revealed, for the first time, that EGR-1 regulates its own transcription and provides important clues on the role of chromatin remodeling and histone modification in EGR-1 transcription. We show that IL-1␤ controls EGR-1 expression via the MEK-ERK1/2 and MSK pathway. EGR-1 binds to and transactivates its own gene, and IL-1␤ induction of EGR-1 transcription involves histone H3 phosphorylation and acetylation. In contrast, p38 is a negative regulator of EGR-1, because SB202190, a selective p38 inhibitor, dose dependently enhances IL-1␤inducible EGR-1 transcription in HASMCs. The opposing influence of different mitogen-activated protein kinases on EGR-1 transcription demonstrates the tight control of this transcription factor at the level of signaling and transcription.
Chromatin structure and remodeling can have a profound influence on gene transcription; however, this influence has been unexplored because of the EGR-1 promoter until the present study. DNA methylation and histone modifications can lead to recruitment of protein complexes that regulate transcription. Our findings demonstrate that histone H3 modifications, acetylation, and phosphorylation, in particular, are associated with IL-1␤-induced EGR-1 transcription in HASMCs. This study investigated the role of histone modification in the EGR-1 promoter, with a focus on H3 (rather than H4), given that H3 is the most extensively modified of the 5 known histones (H1-H5) and that it builds on prior work 39 showing that EGR-1 transcription can be repressed by histone demethylase lysine demethylase 5b, which demethylates lysine 4 of H3. IL-1␤-inducible phosphorylation and acetylation of histone H3 are attenuated by PD98059, consistent with the stimulatory effect of IL-1␤ on phosphorylated ERK1/2, phosphorylated MSK1/2, and EGR-1 mRNA. IL-1␤ Figure 6 . Model of interleukin (IL) 1␤-inducible early growth response (EGR) 1 transcription. The proinflammatory cytokine, IL-1␤, binds to its cell surface receptor and activates the mitogen and stress-activated protein kinase (MEK)extracellular signal-regulated kinase (ERK) 1/2 pathway. Mitogen and stressactivated protein kinase (MSK) 1/2 lies downstream of ERK1/2. MSK1/2 phosphorylation causes the enrichment of phosphorylated H3 at the EGR-1 promoter, and the phosphorylation of ternary complex factors, such as Elk1, which interact with serum response factor (SRF) at serum response elements in the EGR-1 promoter. MSK1/2 is also required in the recruitment of H3 acetyltransferases, such as p300, to the EGR-1 promoter. This increases EGR-1 transcription and protein synthesis, allowing EGR-1 to enter the nucleus, bind its own promoter and associated factors, such as p300, and transactivate itself and other genes, such as TF and plasminogen activator inhibitor (PAI) 1.
causes a rapid and transient induction in acetylated and phosphorylated histone H3, in line with the time course of IL-1␤-induced EGR-1 mRNA expression. Furthermore, histone deacetylase inhibition enhances EGR-1 transcription in HASMCs treated with IL-1␤, clearly indicating a role for histone acetylation in EGR-1 expression. Conversely, suppression of histone modification reduced cytokine-inducible EGR-1 transcription. Although IL-1␤-inducible EGR-1 expression involves H3 acetylation and phosphorylation, Figure  3B and Figures 4A and B do not suggest absolute specificity of H3 acetylation on the EGR-1 gene. SAHA, in the absence of cytokine, caused a dramatic increase in acetylated H3 and EGR-1 mRNA levels ( Figure 3B ). SAHA potentiated IL-1␤inducible EGR-1 expression ( Figure 3B, lower) ; however, SAHA caused little or no change in the total levels of H3 acetylation (Figure 3B, upper) . There are several possible explanations for this. First, it is possible that acetylated H3 was totally recovered from many gene loci, not just those of EGR-1. Second, there may be the involvement of transaction effects, additional to cis-action, induced by H3 acetylation. Alternatively, saturating acetylated H3 levels induced by SAHA would render further increases difficult to detect. Nevertheless, acetylated H3 and phosphorylated H3 were markedly enriched at the EGR-1 promoter by real-time ChIP, further confirming the role of histone modifications in EGR-1 transcription. Histone H3 acetyltransferase and MSK1/2, as well as MEK-ERK1/2, are needed for EGR-1 occupancy of the PAI-1 and TF promoters. EGR-1 physically and functionally interacts with p300 and interacts with its own promoter. Thus, these findings demonstrate that histone H3 modifications are crucial for the transcriptional activation of EGR-1 in cells exposed to IL-1␤, and that EGR-1 controls transcription of its own gene. EGR-1 control of EGR-1 transcription suggests the existence of a "self-amplification" cascade in injured arteries, involving IL-1␤driven chromatin remodeling, EGR-1 and EGR-1-dependent gene expression, a shift to a synthetic cellular and proinflammatory phenotype, and clinical manifestation of vascular disease.
